Binasing, Abdulrazak M.

HRN: 19-50-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
CEFUROXIME 750MG (VIAL)
02/18/2026
02/25/2026
IV
550mg
Q 8 Hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines